ZA90671B - Use of gamma interferons in the preparation of pharmaceutical compositions for the treatment of cancer of the ovary - Google Patents

Use of gamma interferons in the preparation of pharmaceutical compositions for the treatment of cancer of the ovary

Info

Publication number
ZA90671B
ZA90671B ZA90671A ZA90671A ZA90671B ZA 90671 B ZA90671 B ZA 90671B ZA 90671 A ZA90671 A ZA 90671A ZA 90671 A ZA90671 A ZA 90671A ZA 90671 B ZA90671 B ZA 90671B
Authority
ZA
South Africa
Prior art keywords
cancer
ovary
treatment
preparation
pharmaceutical compositions
Prior art date
Application number
ZA90671A
Other languages
English (en)
Inventor
Maud Brandely
Brandely Maud
Danielle Lando
Lando Danielle
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9378406&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA90671(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of ZA90671B publication Critical patent/ZA90671B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA90671A 1989-02-02 1990-01-30 Use of gamma interferons in the preparation of pharmaceutical compositions for the treatment of cancer of the ovary ZA90671B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8901346A FR2644067B1 (fr) 1989-02-02 1989-02-02 Utilisation de certains interferons gamma pour la preparation de compositions pharmaceutiques destinees au traitement du cancer de l'ovaire par voie intraperitoneale

Publications (1)

Publication Number Publication Date
ZA90671B true ZA90671B (en) 1991-04-24

Family

ID=9378406

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA90671A ZA90671B (en) 1989-02-02 1990-01-30 Use of gamma interferons in the preparation of pharmaceutical compositions for the treatment of cancer of the ovary

Country Status (12)

Country Link
EP (1) EP0381584B1 (de)
JP (1) JPH0772137B2 (de)
KR (1) KR100203316B1 (de)
AT (1) ATE99954T1 (de)
AU (1) AU632528B2 (de)
CA (1) CA2009106A1 (de)
DE (1) DE69005837T2 (de)
DK (1) DK0381584T3 (de)
FR (1) FR2644067B1 (de)
HU (1) HU204711B (de)
OA (1) OA09191A (de)
ZA (1) ZA90671B (de)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL76591A0 (en) * 1984-10-05 1986-02-28 Bioferon Biochem Substanz Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
JPH01501792A (ja) * 1986-03-17 1989-06-22 シェリング・コーポレーション γ型インターフェロンによる癌の治療

Also Published As

Publication number Publication date
DK0381584T3 (da) 1994-02-14
HU900202D0 (en) 1990-03-28
OA09191A (fr) 1992-06-30
HU204711B (en) 1992-02-28
EP0381584B1 (de) 1994-01-12
FR2644067A1 (fr) 1990-09-14
EP0381584A3 (de) 1991-11-06
AU632528B2 (en) 1993-01-07
KR100203316B1 (ko) 1999-06-15
EP0381584A2 (de) 1990-08-08
DE69005837D1 (de) 1994-02-24
JPH02235818A (ja) 1990-09-18
FR2644067B1 (fr) 1993-02-05
AU4895390A (en) 1990-08-09
ATE99954T1 (de) 1994-01-15
JPH0772137B2 (ja) 1995-08-02
DE69005837T2 (de) 1994-05-11
CA2009106A1 (fr) 1990-08-02
HUT54302A (en) 1991-02-28
KR900012628A (ko) 1990-09-01

Similar Documents

Publication Publication Date Title
IL87621A0 (en) Conjugates of cytokines with immunoglobulins,their preparation and pharmaceutical compositions containing them
EP0340333A3 (en) Novel physiologically active polypeptide and pharmaceutical composition
ZA907648B (en) Use of a polypeptide having the activity of human interleukine 2 for the preparation of pharmaceutical compositions intended for the treatment of leukemias
DE68909267D1 (de) Medikament zur Behandlung von fibrotischer Störung und antifibrotische Verbindung.
DE3773295D1 (de) Homogene rekombinante immun-interferon-fragmente und diese enthaltende pharmazeutische zusammensetzungen.
ZA904353B (en) Use of a polypeptide having the activity of human interleukin 2 for preparing a pharmaceutical composition intended for the treatment of primary cancers of the pleura
ZA90671B (en) Use of gamma interferons in the preparation of pharmaceutical compositions for the treatment of cancer of the ovary
GR3002779T3 (en) Compositions and the use of interleukin-2 and/or interferon-beta and tumour necrosis factor for combination therapy or in providing medicaments or formulations
NO863027D0 (no) Peptidpreparater med kontinuerlig avgivelse.
EP0180737A3 (en) Use of preparations containing gamma-interferon (ifn-gamma) for treating rheumatic diseases
IL82654A0 (en) Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
EP0267684A3 (en) Human leukocyte interferon composition and skin treatment
DE3869789D1 (de) Behandlung von einigen leukaemien mit einer zusammensetzung von interferon-gamma und interferon-alpha.
DE3777224D1 (de) Verwendung von interferon-beta und interleukin-2 in der kombinationstherapie und zusammensetzungen dazu.
DK0427633T3 (da) Anvendelse af et polypeptid med gammainterferonaktivitet til fremstilling af farmaceutiske præparater beregnet til behandling af primitiv pleuracancer
IL84777A (en) Prevention of bovine respiratory disease complex in cattle by administration of interferon
IL85204A0 (en) Recombinant human interferon beta2,its preparation and pharmaceutical compositions comprising it
HU9200147D0 (en) Medical preparations with human interleukin-2 content
ZA879325B (en) Prevention of bovine respiratory disease complex in cattle by administration of interferon
KR100218699B1 (en) Pharmaceutical composition containing consensus human interferon for the treatment of hairy cell leukemia and kaposi's sarcoma